HSBC Holdings’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162K Buy
+36,331
New +$189K ﹤0.01% 2663
2025
Q3
Sell
-42,609
Closed -$227K 2992
2025
Q2
$227K Buy
42,609
+12,085
+40% +$71.4K ﹤0.01% 2621
2025
Q1
$268K Buy
30,524
+310
+1% +$3.72K ﹤0.01% 2444
2024
Q4
$413K Buy
30,214
+9,997
+49% +$184K ﹤0.01% 2291
2024
Q3
$547K Sell
20,217
-7,976
-28% -$216K ﹤0.01% 1965
2024
Q2
$680K Buy
+28,193
New +$619K ﹤0.01% 1835
2023
Q1
Sell
-17,914
Closed -$253K 2920
2022
Q4
$253K Buy
17,914
+5,076
+40% +$94.6K ﹤0.01% 2653
2022
Q3
$255K Sell
12,838
-9,275
-42% -$213K ﹤0.01% 2500
2022
Q2
$408K Sell
22,113
-3,324
-13% -$69K ﹤0.01% 2456
2022
Q1
$648K Buy
+25,437
New +$651K ﹤0.01% 2224
2021
Q3
Sell
-15,023
Closed -$454K 3102
2021
Q2
$454K Buy
15,023
+6,060
+68% +$175K ﹤0.01% 2251
2021
Q1
$271K Sell
8,963
-6,676
-43% -$189K ﹤0.01% 2362
2020
Q4
$307K Buy
+15,639
New +$253K ﹤0.01% 2553
2020
Q2
Sell
-10,975
Closed -$157K 2796
2020
Q1
$157K Sell
10,975
-3,064
-22% -$64.7K ﹤0.01% 2371
2019
Q4
$387K Buy
+14,039
New +$386K ﹤0.01% 2385
2019
Q2
Sell
-8,124
Closed -$270K 2805
2019
Q1
$270K Buy
+8,124
New +$247K ﹤0.01% 2400
2018
Q3
Sell
-15,900
Closed -$593K 2606
2018
Q2
$593K Buy
+15,900
New +$537K ﹤0.01% 2002
2017
Q4
Sell
-6,962
Closed -$252K 2290
2017
Q3
$252K Buy
+6,962
New +$199K ﹤0.01% 2030
2017
Q1
Sell
-18,268
Closed -$304K 2417
2016
Q4
$304K Buy
+18,268
New +$331K ﹤0.01% 2217
2015
Q4
Sell
-5,930
Closed -$221K 2248
2015
Q3
$221K Sell
5,930
-487
-8% -$17.3K ﹤0.01% 1759
2015
Q2
$218K Sell
6,417
-778
-11% -$26.5K ﹤0.01% 1787
2015
Q1
$255K Buy
7,195
+907
+14% +$32.5K ﹤0.01% 1811
2014
Q4
$214K Buy
+6,288
New +$223K ﹤0.01% 1687

Other funds holding MYGN